| Recruiting | Steroid Use in Treatment of Allergic Reactions to Food NCT07341776 | Johannes Trueck | Phase 4 |
| Enrolling By Invitation | Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis NCT07228325 | Nasus Pharma | Phase 1 / Phase 2 |
| Recruiting | PK/PD Study of IN-001 Sublingual Spray in Healthy Adults NCT07210320 | Insignis Therapeutics, Inc. | Phase 1 |
| Recruiting | Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Ch NCT07038746 | Dr. George Luciuk | Phase 1 |
| Completed | Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Vo NCT06963411 | Kokua Pharma Inc. | Phase 1 |
| Recruiting | Diagnosis and Allergen Identification of Perioperative Anaphylaxis NCT06793163 | Peking University First Hospital | — |
| Recruiting | Analysis of the Role of IgE Proteoforms in Health and Disease NCT07328178 | KU Leuven | — |
| Completed | Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Cha NCT06445374 | Dr. George Luciuk | Phase 1 |
| Completed | Standardised Drug Provocation Testing in Perioperative Hypersensitivity NCT06065137 | University Hospital, Antwerp | N/A |
| Completed | Comparative Bioavailability of Intranasal Epinephrine NCT06205134 | Nasus Pharma | Phase 1 / Phase 2 |
| Completed | A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis NCT07027163 | Novartis Pharmaceuticals | — |
| Active Not Recruiting | Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction NCT05135377 | Waleed Alqurashi | — |
| Unknown | Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Mont NCT05112367 | University Hospital, Montpellier | — |
| Unknown | Study of the Role of Hemostasis in Perioperative Anaphylaxis NCT04825158 | University Hospital, Strasbourg, France | — |
| Completed | Bioavailability of Nasal Epinephrine NCT04696822 | Nasus Pharma | Phase 1 |
| Unknown | Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis NCT04475003 | Algemeen Ziekenhuis Maria Middelares | — |
| Recruiting | Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine NCT04615065 | University Medical Center Groningen | — |
| Completed | Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Inject NCT04207840 | Amphastar Pharmaceuticals, Inc. | Phase 4 |
| Terminated | SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge) NCT04755881 | Université de Sherbrooke | — |
| Completed | What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children NCT03942692 | Hospices Civils de Lyon | — |
| Unknown | Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaph NCT03953482 | Fondation Hôpital Saint-Joseph | — |
| Recruiting | Use of Dexamethasone in Prevention of the Second Phase or a Biphasic Reaction of Anaphylaxis NCT03523221 | Hamad Medical Corporation | Phase 1 |
| Completed | Mast Cell Activation Test in Allergic Disease NCT03406325 | Hong Kong Sanatorium & Hospital | — |
| Completed | Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers NCT03366298 | Imperial College London | Phase 4 |
| Recruiting | A Registry for the Food Allergy Community NCT04653324 | Food Allergy Research & Education | — |
| Active Not Recruiting | Mechanisms of Anaphylaxis NCT03182491 | Haukeland University Hospital | — |
| Completed | Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects NCT03282929 | Bausch & Lomb Incorporated | Phase 1 |
| Completed | Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit NCT04290507 | Central Hospital, Nancy, France | — |
| Completed | Smartphone Apps for Pediatric Resuscitation NCT02958605 | St. Justine's Hospital | N/A |
| Completed | Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device NCT02854969 | Adan Medical Innovation, SL | N/A |
| Unknown | Oral Immunotherapy in Food Allergy in Finland NCT02640014 | Helsinki University Central Hospital | N/A |
| Completed | PEAnut Anaphylaxis Predictors NCT02424136 | John Hunter Children's Hospital | N/A |
| Completed | Observation Periods and Biphasic Reaction Risk Factors in Pediatric Emergency Anaphylaxis Cases NCT07231393 | Aydin Adnan Menderes University | — |
| Completed | A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participan NCT02028065 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy NCT01776489 | Medical University of Vienna | — |
| Unknown | Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis NCT01326741 | Brigham and Women's Hospital | — |
| Unknown | Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vacci NCT01247415 | PHAC/CIHR Influenza Research Network | — |
| Completed | A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine NCT01432522 | Siriraj Hospital | N/A |
| Withdrawn | Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department NCT00657228 | University of Missouri, Kansas City | N/A |
| Completed | Make up for the Epinephrine Autoinjector NCT01217138 | Gazi University | Phase 4 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis NCT00890162 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Desensitization of Human Mast Cells: Mechanisms and Potential Utility for Preventing Anaphylaxis NCT00868842 | Virginia Commonwealth University | — |
| Completed | Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children NCT01361347 | Tampere University Hospital | Phase 4 |
| Recruiting | Acquisition and Long-term Observation of Patients With Severe Allergic Reactions NCT05210543 | Charite University, Berlin, Germany | — |
| Completed | Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing NCT00047918 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Potential Allergens in Wine: Double-blind Placebo-controlled Trial NCT00163735 | Bayside Health | N/A |